A. Crellin

2.9k total citations · 1 hit paper
47 papers, 1.8k citations indexed

About

A. Crellin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, A. Crellin has authored 47 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 19 papers in Surgery and 14 papers in Oncology. Recurrent topics in A. Crellin's work include Advanced Radiotherapy Techniques (13 papers), Radiation Therapy and Dosimetry (12 papers) and Esophageal Cancer Research and Treatment (11 papers). A. Crellin is often cited by papers focused on Advanced Radiotherapy Techniques (13 papers), Radiation Therapy and Dosimetry (12 papers) and Esophageal Cancer Research and Treatment (11 papers). A. Crellin collaborates with scholars based in United Kingdom, United States and Australia. A. Crellin's co-authors include J I Geh, Rob Glynne‐Jones, David Cunningham, Joyce Thompson, Stephen Falk, David Sebag‐Montefiore, Juan W. Valle, F. Adab, Janet Dunn and David B. Smith and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

A. Crellin

44 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

2009 602 citations David Cunningham, Stephen Falk et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Crellin United Kingdom	20	1.0k	857	809	354	185	47	1.8k
Jessica M. Frakes United States	21	849 0.8×	689 0.8×	579 0.7×	273 0.8×	227 1.2×	144	1.6k
F. Adab United Kingdom	10	906 0.9×	939 1.1×	849 1.0×	267 0.8×	209 1.1×	14	2.2k
Rafael Martínez‐Monge Spain	27	926 0.9×	984 1.1×	919 1.1×	153 0.4×	174 0.9×	128	2.3k
Katja Lindel Germany	22	708 0.7×	466 0.5×	610 0.8×	374 1.1×	358 1.9×	60	1.9k
J.-F. Bosset France	15	1.6k 1.6×	699 0.8×	695 0.9×	274 0.8×	275 1.5×	43	1.9k
Antoine Lusinchi France	23	745 0.7×	859 1.0×	1.2k 1.5×	209 0.6×	125 0.7×	34	2.2k
Kinji Nishiyama Japan	22	521 0.5×	727 0.8×	768 0.9×	150 0.4×	239 1.3×	63	1.6k
Eugenio Villa Italy	25	841 0.8×	769 0.9×	404 0.5×	176 0.5×	192 1.0×	52	1.9k
Mian Xi China	23	503 0.5×	837 1.0×	893 1.1×	225 0.6×	97 0.5×	105	1.6k
Michael D. Chuong United States	23	1.2k 1.2×	1.2k 1.4×	621 0.8×	479 1.4×	321 1.7×	157	2.2k

Countries citing papers authored by A. Crellin

Since Specialization

Citations

This map shows the geographic impact of A. Crellin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Crellin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Crellin more than expected).

Fields of papers citing papers by A. Crellin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Crellin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Crellin. The network helps show where A. Crellin may publish in the future.

Co-authorship network of co-authors of A. Crellin

This figure shows the co-authorship network connecting the top 25 collaborators of A. Crellin. A scholar is included among the top collaborators of A. Crellin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Crellin. A. Crellin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crellin, A., Daniel J. Indelicato, K.J. Kirkby, et al.. (2023). Equity of Access to Proton Beam Therapy in England: A National NHS analysis. International Journal of Radiation Oncology*Biology*Physics. 117(2). e19–e19.

Aznar, Marianne, N.G. Burnet, A. Crellin, et al.. (2023). Assessing Equity of Access to Proton Beam Therapy: A Literature Review. Clinical Oncology. 35(9). e528–e536. 17 indexed citations

Marvaso, Giulia, A. Crellin, Marianne Aznar, et al.. (2023). Proton Beam Therapy in the Oligometastatic/Oligorecurrent Setting: Is There a Role? A Literature Review. Cancers. 15(9). 2489–2489. 5 indexed citations

Burnet, N.G., Marianne Aznar, A. Crellin, et al.. (2022). Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review. Clinical Oncology. 34(6). e225–e237. 12 indexed citations

Hwang, Eunji, N.G. Burnet, A. Crellin, et al.. (2021). A Novel Model and Infrastructure for Clinical Outcomes Data Collection and Their Systematic Evaluation for UK Patients Receiving Proton Beam Therapy. Clinical Oncology. 34(1). 11–18. 19 indexed citations

Kirkby, K.J., N.F. Kirkby, N.G. Burnet, et al.. (2020). Heavy charged particle beam therapy and related new radiotherapy technologies: The clinical potential, physics and technical developments required to deliver benefit for patients with cancer. British Journal of Radiology. 93(1116). 20200247–20200247. 16 indexed citations

Jones, Christopher M., Katie Spencer, Bradford J. Wood, et al.. (2019). Hypofractionated Radiotherapy in Oesophageal Cancer for Patients Unfit for Systemic Therapy: A Retrospective Single-Centre Analysis. Clinical Oncology. 31(6). 356–364. 24 indexed citations

White, Judith, Grace Carolan‐Rees, Megan Dale, et al.. (2019). Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A Prospective, Observational Study. Journal of Vascular and Interventional Radiology. 30(8). 1185–1192. 36 indexed citations

Alderson, Derek, David Cunningham, Matthew Nankivell, et al.. (2017). Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial. The Lancet Oncology. 18(9). 1249–1260. 149 indexed citations

10.

Spencer, Katie, Rebecca Birch, David Sebag‐Montefiore, et al.. (2017). Caution is required in the implementation of 90-day mortality indicators for radiotherapy in a curative setting: A retrospective population-based analysis of over 16,000 episodes. Radiotherapy and Oncology. 125(1). 140–146. 9 indexed citations

11.

Ward, Gillian, Jonathan Sykes, Robin Prestwich, et al.. (2016). Superiority of Deformable Image Co-registration in the Integration of Diagnostic Positron Emission Tomography-Computed Tomography to the Radiotherapy Treatment Planning Pathway for Oesophageal Carcinoma. Clinical Oncology. 28(10). 655–662. 8 indexed citations

12.

Cunningham, David, Ruth E. Langley, Matthew Nankivell, et al.. (2015). LBA-03 Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072). Annals of Oncology. 26. iv117–iv117. 7 indexed citations

13.

Hatfield, Paul, Mohan Hingorani, Ganesh Radhakrishna, et al.. (2009). Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity. Radiotherapy and Oncology. 92(2). 210–214. 94 indexed citations

14.

Morgan, Andrew, et al.. (2004). The Clinical Implications of the Collapsed Cone Planning Algorithm. Clinical Oncology. 16(2). 148–154. 24 indexed citations

15.

Mikeljevic, J Stefoski, Raymond Haward, C.F. Johnston, et al.. (2004). Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgery. British Journal of Cancer. 90(7). 1343–1348. 84 indexed citations

16.

Patel, Kinnari, et al.. (2004). Weekly 5-fluorouracil and leucovorin: achieving lower toxicity with higher dose-intensity in adjuvant chemotherapy after colorectal cancer resection. Annals of Oncology. 15(4). 568–573. 22 indexed citations

17.

Thomas‐Jones, Emma, A. Crellin, Keith M. Harris, S. Swift, & David Sebag‐Montefiore. (2004). The role of endoscopic ultrasound (EUS) in planning radiotherapy target volumes for oesophageal cancer. Radiotherapy and Oncology. 73(2). 149–151. 11 indexed citations

18.

Crellin, A., B. Vaughan Hudson, M.H. Bennett, S.J. Harland, & G. Vaughan Hudson. (1993). Non-Hodgkin's lymphoma of the testis. Radiotherapy and Oncology. 27(2). 99–106. 66 indexed citations

19.

Dodwell, David, et al.. (1993). Effect of medical audit on prescription of palliative radiotherapy.. BMJ. 307(6895). 24–25. 5 indexed citations

20.

Crellin, A., A Marks, & E.J. Maher. (1989). Why don't British radiotherapists give single fractions of radiotherapy for bone metastases?. Clinical Oncology. 1(2). 63–66. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact